Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
DNA Bacteriophages01:26

DNA Bacteriophages

790
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
790
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

1.3K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the Phage Properties Best for Therapy.

Viruses·2026
Same author

Waning immunity drives respiratory virus evolution and reinfection.

Evolution, medicine, and public health·2025
Same author

Mathematical comparison of protocols for adapting a bacteriophage to a new host.

Virus evolution·2024
Same author

Quality of patient-oriented online information on treatment of dementia: A comparative assessment of web pages in English and Hindi language.

Indian journal of psychiatry·2024
Same author

Controlling Recombination to Evolve Bacteriophages.

Cells·2024
Same author

Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect.

Expert review of vaccines·2024

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
08:46

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

2.5K

Modeling the phage properties best for therapy.

James J Bull1, Gurneet Kaur2, Stephen M Krone3

  • 1Dept of Biological Sciences, University of Idaho, Moscow, ID USA.

Biorxiv : the Preprint Server for Biology
|January 9, 2026
PubMed
Summary
This summary is machine-generated.

Phage therapy success can be predicted by phage adsorption and growth rates, not burst size or lysis time. Optimizing these phage properties may improve treatment outcomes for bacterial infections.

More Related Videos

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.5K
Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
09:40

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins

Published on: June 11, 2015

12.7K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
08:46

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

2.5K
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.5K
Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
09:40

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins

Published on: June 11, 2015

12.7K

Area of Science:

  • Microbiology
  • Computational Biology
  • Biophysics

Background:

  • Phage therapy uses bacteriophages to treat bacterial infections.
  • Current phage selection often focuses on host range, but therapy success varies.
  • Improved predictors for phage efficacy are needed.

Purpose of the Study:

  • To computationally model phage properties as predictors of phage therapy success.
  • To identify key phage characteristics influencing treatment efficacy.

Main Methods:

  • Simulated 2400 combinations of phage phenotypes (burst size, lysis, adsorption, decay rate, growth rate).
  • Calculated the number of phages needed to reduce bacterial density 100-fold.
  • Analyzed the predictive value of each phage property.

Main Results:

  • Adsorption rate and growth rate were the most significant predictors of phage therapy success.
  • Decay rate showed some predictive value, while burst size and lysis time had minimal impact.
  • Bacterial density was highly informative regarding required phage numbers.
  • High and low bacterial densities benefit from optimized adsorption and growth rates.

Conclusions:

  • Phage adsorption and growth rates are critical for effective phage therapy.
  • Selection for broad host range may negatively impact adsorption and growth on specific hosts.
  • Computational modeling can guide the selection and engineering of phages for improved therapeutic outcomes.